Sangamo Therapeutics Inc (SGMO): Next-Year EPS Estimate 71.05%
As of 2026-05-07, Sangamo Therapeutics Inc (SGMO) has a next-year EPS growth estimate of 71.05%.
On 2026-04-01, analyst consensus for SGMO's next-year EPS growth shifted from 79.71% to 71.05% — a negative change of 8.66 percentage points. The revised estimate has been sustained across 30 subsequent trading sessions. Current-year growth is projected at 56.82%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 71.05%
- EPS growth this year
- 56.82%
- EPS next quarter (est)
- $0.01
- Last price
- $0.18
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-05-07 | 71.05% | 56.82% | $0.01 | $0.18 |
| 2026-05-06 | 71.05% | 56.82% | $0.01 | $0.18 |
| 2026-05-05 | 71.05% | 56.82% | $0.01 | $0.18 |
| 2026-05-04 | 71.05% | 56.82% | $0.01 | $0.18 |
| 2026-05-03 | 71.05% | 56.82% | $0.01 | $0.14 |
| 2026-04-30 | 71.05% | 56.82% | $0.01 | $0.12 |
| 2026-04-29 | 71.05% | 56.82% | $0.01 | $0.13 |
| 2026-04-28 | 71.05% | 56.82% | $0.01 | $0.20 |
| 2026-04-27 | 71.05% | 56.82% | $0.01 | $0.21 |
| 2026-04-26 | 71.05% | 56.82% | $0.01 | $0.19 |
| 2026-04-24 | 71.05% | 56.82% | $0.01 | $0.19 |
| 2026-04-23 | 71.05% | 56.82% | $0.01 | $0.25 |
| 2026-04-22 | 71.05% | 56.82% | $0.01 | $0.26 |
| 2026-04-21 | 71.05% | 56.82% | $0.01 | $0.26 |
| 2026-04-20 | 71.05% | 56.82% | $0.01 | $0.27 |
| 2026-04-19 | 71.05% | 56.82% | $0.01 | $0.26 |
| 2026-04-16 | 71.05% | 56.82% | $0.01 | $0.27 |
| 2026-04-15 | 71.05% | 56.82% | $0.01 | $0.28 |
| 2026-04-14 | 71.05% | 56.82% | $0.01 | $0.26 |
| 2026-04-13 | 71.05% | 56.82% | $0.01 | $0.26 |
| 2026-04-12 | 71.05% | 56.82% | $0.01 | $0.25 |
| 2026-04-10 | 71.05% | 56.82% | $0.01 | $0.26 |
| 2026-04-09 | 71.05% | 56.82% | $0.01 | $0.26 |
| 2026-04-08 | 71.05% | N/A | $0.01 | $0.25 |
| 2026-04-07 | 71.05% | N/A | $0.01 | $0.26 |
| 2026-04-06 | 71.05% | N/A | $0.01 | $0.26 |
| 2026-04-05 | 71.05% | N/A | $0.01 | $0.30 |
| 2026-04-03 | 71.05% | N/A | $0.01 | $0.26 |
| 2026-04-02 | 71.05% | N/A | $0.01 | $0.26 |
| 2026-04-01 | 71.05% | N/A | $0.01 | $0.26 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Sangamo Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-05-07, Sangamo Therapeutics Inc (SGMO) has a next-year EPS growth estimate of 71.05%, based on analyst consensus.
When was the latest EPS estimate revision for SGMO?▾
The most recent revision occurred on 2026-04-01, when analysts adjusted the next-year EPS growth estimate from 79.71% to 71.05%.
What sector and industry does Sangamo Therapeutics Inc belong to?▾
Sangamo Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. SGMO appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Sangamo Therapeutics Inc (SGMO) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports